Hear from Shaw and Partners’ Chief Investment Officer Martin Crabb who will discuss the key issues facing investors in 2022 including the volatility in global equity markets.

In this event, you will also hear from ASX listed company CEOs and discover new opportunities to invest.

Not to be missed

2 hours unstructured CPD for advisers

Register now and secure your virtual seat.

Tuesday, 24 May 2022

Online Live Streaming Event
15 mins presentations
Starts at 12.30 PM (Sydney, GMT+11:00)
Free for investors, brokers and fund managers

Market Update 

Event Partner

Martin Crabb
(Chief Investment Officer), Shaw and Partners 

An overview of the market action and the themes taking investor’s attention in the current investment landscape.

Presenting Companies 


12:40pm - John Thompson (Managing Director), Knosys (ASX:KNO)

Knosys (ASX:KNO) is a global software-as-service technology provider with 260 clients across banking, health, telecommunications, retail and financial services. The technology provider helps boost productivity, collaboration and connectivity in the digital workplace through knowledge management and employee experience solutions.


12:55pm - Mark Simari (Executive Chairman), CARETEQ (ASX:CTQ)

CARETEQ (ASX:CTQ) delivers technology solutions that monitor events such as fall detection, and movement patterns for the health and aged care sector. The biotech provider is the owner of Australia’s largest medication management service provider, Ward Medication.

01:10pm - Lawrence Lun (CEO), eCargo (ASX:ECG)

eCargo (ASX:ECG) helps companies sell in Asia with a particular focus in China by providing end-to-end services. This includes logistics, market activation, content generation, brand management, sales and distribution, working with over 80 brands across fashion, beauty, personal care and food.

01:25pm - Marc Voigt (Executive Director & CEO), Immutep (ASX:IMM), (NASDAQ:IMMP)

Immutep (ASX:IMM) develops novel immunotherapy treatments for cancer and autoimmune disease. The company’s aim is to enable the patient's own immune system to actively fight cancer. The biotech has one pre-clinical and three clinical LAG-3 product candidates under development through pharmaceutical partnerships with Novartis and GlaxoSmithKline.

01:40pm - Joe Walsh (Managing Director), Lepidico (ASX:LPD), (FRA:AUB)

Lepidico (ASX:LPD) is a global lithium miner that can leach lithium and other valuable metals from micro minerals through its proprietary technology L-Max®. The explorer has wholly owned projects and joint ventures in Australia, Canada, Brazil, and Argentina.

Future 2022 Events

28 June | 26 July | 23 August | 20 September 
25 October | 22 November | 13 December 


Event Sponsors


Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.